Prior notification of a concentration (Case M.10585 – APMH INVEST / UNILABS) Candidate case for simplified procedure (Text with EEA relevance) 2021/C 523/07
Date: 2021-12-28
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, investment company, medical diagnosis, merger control, pharmaceutical industry, provision of services








C_2021523EN.01000801.xml










28.12.2021   


EN


Official Journal of the European Union


C 523/8






Prior notification of a concentration
(Case M.10585 – APMH INVEST / UNILABS)
Candidate case for simplified procedure
(Text with EEA relevance)
(2021/C 523/07)

1.   
On 17 December 2021 the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


APMH Invest A/S (‘APMHI’, Denmark), controlled by A.P. Møller Holding A/S (‘APMH’, Denmark);










—


Unilabs Holding AB (‘Unilabs’, Switzerland), controlled by Cidra GP S.à.r.l (Luxembourg).




APMHI acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Unilabs.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are:






—


for APMHI: globally active investment company, with investments in Maersk Tankers, Maersk Product Tankers, A.P. Moller Capital, KK Wind Solutions Holding A/S, Faerch, Nissens Cooling Solutions, Maersk Drilling, Danske Bank A/S and other financial investments in fixed income and securities. APHM also controls A.P. Møller-Mærsk A/S, an integrated transport and logistics company with worldwide activities.










—


for Unilabs: provider of diagnostic services, which is active in the provision of bio-medical testing services (also known as CLTS), medical imaging services, reproductive medicine services and drug development services. It has laboratories and/or imaging centres in several EU- and non-EU countries.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.10585 – APMH INVEST / UNILABS
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.